Use of ER&bgr;-selective ligands for regulating fertility and compounds useful therefor

US6794409B2 · kind B2 · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Christa Hegele-Hartung · Neheim, DE
• Karl-Heinrich Fritzemeier · Berlin, DE
• Hiroshi Yamanouchi · Berlin, DE
• Olaf Peters · Bad Tabarz, DE
• Dirk Kosemund · Berlin, DE
• Gerd Mueller · Hamburg, DE
• Ingo Tornus · Hennigsdorf, DE
• Gerd Schubert · Jena, DE
• Sven Ring · Jena, DE

Key dates

• Filing date: Feb 27, 2002
• Grant date: Sep 21, 2004
• Expiry date: Feb 27, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P5/24
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention discloses the use of ER&bgr;-selective ligands for production of medicaments for regulating fertility without additional use of a progestin.ER&bgr;-agonists are used for treatment of infertility and ER&bgr;-antagonists for contraception.